शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
HCGNSEHealthcare Global Enterprises Limited· Healthcare ServicesHighNegative
Announced Mon, 25 May, 2026 · 18:19 IST

Healthcare Global Enterprises Limited has informed the Exchange about Resignation of Director/KMP/SMP

Key managerial personnel resignedManagement Changes View source PDFExplain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹658.00
prior close
₹648.35
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%-1.0% vs market
Hospital peers, median of 23sector+0.0%-0.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.8
10m
+0.4
15m
+0.6
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.7-1.0+0.0-0.3
Next day
+0.3+0.7-0.4-0.1+0.4
2d
-3.5+0.0-3.5-0.9-2.6
3d
-1.8-1.1-0.8-1.5-0.3
4d
-3.9+0.0-4.0-0.4-3.5
5d
-3.8+0.3-4.0-0.0-3.7
1w
-3.0+1.1-4.1+1.4-4.5
15d
-4.1+4.9-9.0+0.1-4.2
1m
-9.7+5.3-15.0+2.9-12.6
2m
+3.5+6.9-3.4+3.6-0.1
3m
+7.5+11.9-4.4+3.8+3.7
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Healthcare Global Enterprises (HCG) announced that Dr. Manish Mattoo has stepped down from the additional charge of Interim Chief Financial Officer (CFO) effective May 25, 2026. This comes after the company's board appointment of Mr. Sanjeev Kumar as the new permanent CFO, who assumed office on the same date. Dr. Mattoo was serving as Interim CFO since December 2025, having taken on the additional responsibility when the previous CFO left. Importantly, Dr. Mattoo remains with the company as Executive Director and Chief Executive Officer. The company expressed appreciation for his leadership during his tenure as Interim CFO.

Likely market impact

This announcement indicates smooth transition in the finance leadership with no red flags. The appointment of a permanent CFO replacing the interim arrangement provides stability and clarity on the finance function. Shareholders can view this positively as it fills a key management position.